Market Research Logo

Global Cystic Fibrosis Therapeutics Market 2018-2022

Global Cystic Fibrosis Therapeutics Market 2018-2022

About Cystic Fibrosis Therapeutics

CF is a genetic disorder that mostly affects the lungs and sometimes other parts of the body such as the liver, pancreas, intestines, and the kidneys. The disease is inherited in an autosomal recessive manner. It is due to mutations caused in both the copies of the gene for the CFTR protein.

Technavio’s analysts forecast the global cystic fibrosis therapeutics market to grow at a CAGR of 17.28% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cystic Fibrosis Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • Gilead
  • F. Hoffmann-La Roche
  • Vertex Pharmaceuticals
Market driver
  • Improved diagnostic technologies
  • For a full, detailed list, view our report
Market challenge
  • Drug discontinuation
  • For a full, detailed list, view our report
Market trend
  • Strategic collaborations
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Cystic Fibrosis Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global cystic fibrosis therapeutics market: AbbVie, Gilead, F. Hoffmann-La Roche, and Vertex Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is strategic collaborations. M&A are usually intended to enhance a company's product portfolio and increase the acquiring company's market penetration. Established pharmaceutical companies acquire late-stage products from small companies, where the efficacy of products has already been demonstrated, thereby cutting down on initial R&D expenditure.”

According to the report, one driver in the market is improved diagnostic technologies. CF is a genetically inherited disease. Several diagnostic tests are available to detect the disease. Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests. Growing investment in and awareness about genetic diseases are expected to lead to improved diagnostic technologies, which will drive the growth of the market.

Further, the report states that one challenge in the market is drug discontinuation. Discontinuation of drugs from the development stage or from the market after their launch is a major challenge for investors and drug manufacturers. The discontinuation of drugs from the late-stage development or after approval due to reasons such as safety concerns leads to a significant financial loss for investors because of the high R&D and marketing costs involved in the process of drug development.

Companies Mentioned

AbbVie, Gilead, F. Hoffmann-La Roche, and Vertex Pharmaceuticals.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Autosomal recessive pattern of inheritance in CF
      • Table Effects of CF on different body parts
      • Table Most common CFTR mutations
      • Table Global birth prevalence of CF by 2017
      • Table Diagnosis and treatment of CF
  • Market landscape
    • Market ecosystem
      • Table Parent market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing
      • Table Market size
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global CF therapeutics market 2017-2022 ($ millions)
      • Table Global CF therapeutics market: Year over year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Market segmentation by drug class
    • Table Global CF therapeutics market by drug class 2017-2022 (% share)
    • Comparison by drug class
      • Table Comparison by drug class
    • CFTR modulators
      • Table Global CF therapeutics market by CFTR modulators 2017-2022 ($ millions)
      • Table KALYDECO description
      • Table ORKAMBI description
      • Table Global CF therapeutics market by CFTR modulators: Year over year growth 2018-2022 (%)
    • Mucolytics
      • Table Global CF therapeutics market by mucolytics 2017-2022 ($ millions)
      • Table Global CF therapeutics market by mucolytics: Year over year growth 2018-2022 (%)
    • PERT
      • Table Global CF therapeutics market by PERT 2017-2022 ($ millions)
      • Table Global CF therapeutics market by PERT: Year over year growth 2018-2022 (%)
    • Anti-infectives
      • Table Global CF therapeutics market by anti-infectives 2017-2022 ($ millions)
      • Table Global CF therapeutics market by anti-infectives: Year over year growth 2018-2022 (%)
    • Bronchodilators
      • Table Global CF therapeutics market by bronchodilators 2017-2022 ($ millions)
      • Table Global CF therapeutics market by bronchodilators: Year over year growth 2018-2022 (%)
    • Market opportunity by drug class
      • Table Market opportunity by drug class
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Table Global CF therapeutics market by region 2017-2022 (% share)
    • Regional comparison
      • Table Regional comparison
    • CF therapeutics market in Americas
      • Table CF therapeutics market in Americas 2017-2022 ($ millions)
      • Table CF therapeutics market in Americas: Year over year growth 2018-2022 (%)
      • Table Top three countries in Americas
    • CF therapeutics market in EMEA
      • Table CF therapeutics market in EMEA 2017-2022 ($ millions)
      • Table CF therapeutics market in EMEA: Year over year growth 2018-2022 (%)
      • Table Top three countries in EMEA
    • CF therapeutics market in APAC
      • Table CF therapeutics market in APAC 2017-2022 ($ millions)
      • Table CF therapeutics market in APAC: Year over year growth 2018-2022 (%)
      • Table Top three countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market Drivers
      • Table Few drugs with breakthrough therapy designation for CF
      • Table Few drugs with Orphan Drug Designation for CF
    • Market challenges
      • Table Few CF therapeutics discontinued from development
  • Market trends
    • Strategic collaborations
      • Table Partnerships and collaborations between companies for development of CF therapeutics
    • Advances in technology for drug development and delivery
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
      • Table Competitive structure analysis of global CF therapeutics market 2017
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie: Overview
      • Table AbbVie: Business segments
      • Table AbbVie: Organizational developments
      • Table AbbVie: Geographic focus
      • Table AbbVie: Segment focus
      • Table AbbVie: Key offerings
      • Table AbbVie: Key customers
    • Gilead
      • Table Gilead: Overview
      • Table Gilead: Business segments
      • Table Gilead: Organizational developments
      • Table Gilead: Geographic focus
      • Table Gilead: Segment focus
      • Table Gilead: Key offerings
      • Table Gilead: Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Overview
      • Table F. Hoffmann-La Roche: Business segments
      • Table F. Hoffmann-La Roche: Organizational developments
      • Table F. Hoffmann-La Roche: Geographic focus
      • Table F. Hoffmann-La Roche: Segment focus
      • Table F. Hoffmann-La Roche: Key offerings
      • Table F. Hoffmann-La Roche: Key customers
    • Vertex Pharmaceuticals
      • Table Vertex Pharmaceuticals: Overview
      • Table Vertex Pharmaceuticals: Business segments
      • Table Vertex Pharmaceuticals: Organizational developments
      • Table Vertex Pharmaceuticals: Geographic focus
      • Table Vertex Pharmaceuticals: Segment focus
      • Table Vertex Pharmaceuticals: Key offerings
      • Table Vertex Pharmaceuticals: Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report